Provided is the use of a prolactin or prolactin releasing peptide and an interferon-â for the manufacture of a medicament for treating or ameliorating a neuroinflammatory or demyelinating disorder in a mammal. The disorder can be multiple sclerosis, myelitis or central nervous system injury. Further provided are compositions comprising the two components.
